psilocybin
psilocybin: 17 clinical trials tracked.
psilocybin evidence translation
What we can confirm
17 tracked trials
What it means
What to watch
Prepared research question
What is verified about psilocybin, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence5 indications · 5 study sponsors
Related indications
Clinical Trials (17)showing 10 most recent
Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial
Primary endpoint: Opioid Abstinence
Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
Primary endpoint: Neurofeedback
Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury
Primary endpoint: Number of Participants with Treatment-Related Adverse Events as Assessed by the Adverse Events Log.
A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans
Primary endpoint: Montgomery-Asberg Rating Scale (MADRS)
Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia
Primary endpoint: Change in Dimensional Anhedonia Rating Scale (DARS) Score
A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)
Primary endpoint: To assess the safety and tolerability of psilocybin-assisted therapy in adult participants with PTSD secondary to sexual assault
PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial
Primary endpoint: Change in Psychological Distress - Patient Global Impression of Change
Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
Primary endpoint: Feasibility of psilocybin treatment as assessed by number of participants recruited, retained and adhere to treatment
Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life
Primary endpoint: Change in patient-reported Demoralization Scale-II..
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
Primary endpoint: Change in Massachusetts General Hospital Rumination Questionnaire (MGH-RQ)